Meet the Scientist
Sarah Almond, MSc, Associate Director of Biology
Having once sat on the other side of the bench as a Charles River client, Associate Director of Integrated Biology Sarah Almond is intimately familiar with the pressures facing today’s drug seekers. Her experience working for a couple of Cambridge-area companies informs her approach to finding creative solutions to their toughest challenges. In her current role, she splits her time between managing the daily operations of integrated discovery programs across Charles River’s CNS sites, and building new client partnerships. She has a keen interest in further expanding her department’s existing proteomics capabilities and in showing clients how to move their CNS research efficiently from in vitro to in vivo studies. Professionally, Sarah Almond leads the company’s involvement with the Psychiatry Consortium, a joint initiative with the Medicines Catapult and the Dementia Consortium that brings together academia, industry, charity, and government-funded organizations to bring forward novel targets for the treatment of CNS disorders.
Translating Neurological Stem Cell Research Into Therapies for Today's Patients
December 8th, 2020 | 9:00 a.m. - 5:00 p.m.
AC Hotel by Marriott | South San Francisco, CA 94080Read more